The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report to 30 September 2018

21 Nov 2018 13:00

RNS Number : 1023I
British Smaller Companies VCT PLC
21 November 2018
 

British Smaller Companies VCT plc

Unaudited Interim Results and Interim Management Report

For the six months ended 30 September 2018

British Smaller Companies VCT plc (the "Company") today announces its unaudited interim results for the six months to 30 September 2018.

HIGHLIGHTS

· Increase in total return of 3.0 pence per ordinary share to 219.0 pence per ordinary share at 30 September 2018 (216.0 pence per ordinary share as at 31 March 2018).

· Increase in net asset value ("NAV") to 82.6 pence per ordinary share prior to the payment of the interim dividend of 4.0 pence per ordinary share in May 2018. The NAV at 30 September 2018 is 78.6 pence per ordinary share.

· Total dividends for the period ended 30 September 2018 amounted to 4.0 pence per ordinary share which equates to 5.0 per cent of the opening March 2018 NAV per share.

· Total cumulative dividends paid since inception of 140.4 pence per ordinary share.

· The Company invested £3.12 million into two new investments during the period.

· The Company will shortly launch an offer, with British Smaller Companies VCT2 plc, (together "the Companies"), to raise up to £30 million in aggregate, with an additional £5 million over allotment facility, by way of a new joint prospectus offer of new ordinary shares for subscription in the 2018/19 tax year ("the Offer"). The Offer will be open to those shareholders on the register of one or both of the Companies on 22 October 2018 until 4 January 2019, and unless the Offer has been fully subscribed by that date the Offer will then be available to new Investors.

CHAIRMAN'S STATEMENT

I am pleased to present the Interim Accounts for the six months ended 30 September 2018.

Overview

Total Return for the six months was 3.0 pence per ordinary share, which was 3.8 per cent of the net asset value at 31 March 2018.

New Investment

It is pleasing that in the first six months of 2018, your Company completed two new investments totalling £3.1 million. These were:

£1.3 million was invested into Hutchinson Networks Limited in April 2018, a leading provider of multi-vendor IT and network solutions to clients globally. Hutchinson will utilise the money to fund additional marketing and operational resources to accelerate international growth in a growing market.

£1.8 million was invested into Arcus Global Limited in May 2018, a provider of cloud-based software solutions to local and national public-sector organisations. The funding will support the continued growth of the business; building resource in technology development, sales and customer services. Together, this will enable Arcus to further expand its range of software solutions to help the public sector to increase its use of digital technologies and transform services.

In both cases there is the prospect that follow-on funding may be required.

Financial Results and Dividends

The movement in Total Return is set out in the table below:

 

 

Total Return

 

Pence per

ordinary share

Total Return at 1 April 2018

216.0

Net underlying increase in portfolio

3.0

Total Return at 30 September 2018

219.0

The portfolio produced a value gain of £3.3 million, representing a 5.1 per cent increase over the opening value and equivalent to an increase in value for shareholders of 3.0 pence per ordinary share.

Due to the repayment of loans and the different financing structures of new investments there has been a significant change in the nature of the Company's income. Newer investments now include lower levels of debt and higher levels of preference shares, which means that a growing proportion of income now derives from preference dividends. In addition, where new investments are re-investing their profits to fund growth, the payment of dividends and interest is often deferred until a sale.

Whilst income in the period was slightly higher than the same period last year, this derived principally from preference dividends as referred to above - the receipt of which is anticipated to be less predictable than the interest income from more mature investments.

Investments made since the changes to the VCT rules in November 2015 now comprise £18.7 million (29 per cent) of the value of the unquoted portfolio as at 30 September 2018, with £45.6 million (71 per cent) of investments made prior to the rule changes. In general, the more recent additions to the portfolio comprise mainly equity instruments. Additionally because younger companies typically re-invest their profits for growth, they may have little or no capacity to pay dividends.

An interim dividend of 4.0 pence per ordinary share in respect of the year ending 31 March 2019 was paid in the period, bringing the cumulative dividends paid to date to 140.4 pence per ordinary share.

The movement in net asset value per ordinary share and the dividends paid are set out in the table below:

 

Net Asset Value "NAV"

 

£000

Pence per

ordinary share

NAV at 1 April 2018

86,137

79.6

Net underlying increase in portfolio

3,307

3.0

Profit for the period

33

-

Issue/buy-back of shares

63

-

3,403

3.0

NAV before the payment of dividends

89,540

82.6

Dividends paid

(4,322)

(4.0)

NAV at 30 September 2018

85,218

78.6

Shareholder Relations

As part of the Board's continuing dialogue with shareholders, the 23rd shareholder workshop was held in conjunction with British Smaller Companies VCT2 plc at the Honourable Artillery Company on 16 May 2018. This included a presentation from the CEO of one of our newest investments, Ncam Technologies Limited, along with short videos about some of the new portfolio companies. The Company's performance, portfolio and outlook were discussed in talks given by the Investment Adviser, followed by a question and answer session.

As shareholders may be aware the General Data Protection Regulations ("GDPR") came into force on 25 May 2018. GDPR provides a greater level of protection over personal information and the Company and the Investment Adviser have taken all necessary steps to comply with its requirements. A revised Privacy Notice has been published and this can be found on your Company's website at www.bscfunds.com.

A large number of shareholders (83 per cent) now receive documents such as the annual report via the website, www.bscfunds.com, rather than by post. This saves on printing costs, as well as being more environmentally friendly, and your Board would encourage all shareholders to do this.

Your Company's website www.bscfunds.com, provides a comprehensive level of information in what I hope is a user-friendly format and is refreshed on a regular basis.

Regulatory Developments

On 5 July 2018 the European Commission confirmed its approval of the recent amendments to the VCT rules, including a higher annual investment limit for Knowledge Intensive Companies of £10 million which, for appropriate investments, your Company intends to utilise.

HMRC launched a consultation on proposed changes to the advance assurance process which would allow your Company to make investments without obtaining advance assurance. The Board continues to keep these developments under review.

Fundraising

Following a review of the Company's cash requirements, the Board will shortly launch a joint offer for subscription with British Smaller Companies VCT2 plc, to raise in aggregate £30 million, with an additional £5 million over allotment facility. There will be a short period of time during which existing shareholders of both companies will have exclusivity for around four weeks to apply for new shares in both companies on a first-come, first-served basis, after which the offers will be open to new investors. The intention is to have a single allotment, which will be between 1-5 April 2019, in order to maximise the time available to invest the monies raised and meet the VCT qualifying rules.

Board Composition

After 9 years as a non-executive director Edward Buchan has decided to retire from the Board at the 2019 Annual General Meeting. His thoughtful approach as Chair of the Audit Committee has been invaluable to the Company, and I thank him for the considerable contribution he has made to its development. His contribution to the Board will be greatly missed. The Board intends to begin the process of recruiting a new non-executive director and Chair of the Audit Committee early in 2019.

Outlook

The Board welcomes the European Commission's approval of the recent changes to the VCT rules, especially the ability to invest up to £10 million in any one year into Knowledge Intensive Companies as this should allow investments to be accelerated in certain cases.

While it is frustrating that there is little clarity on the UK's future trading relationship with the EU the businesses in the portfolio continue to prepare for all potential outcomes. There has been little impact on the level of enquiries seen by the Investment Adviser to date.

The more mature investments in the portfolio generally continue to perform well, as can be seen from the valuation uplifts in this period, and opportunities to realise these investments are pursued where the timing is felt to be appropriate for the relevant business. The level of investment pipeline and the expected financial needs of the newer growth investments informs the requirement to raise further funds at this time. Your Board hopes that shareholders will take the opportunity to further invest in the Company in the proposed fundraising.

I would like to take this opportunity to thank shareholders for their continued support.

OBJECTIVES AND KEY POLICIES

The Company's objective is to grow Total Return over the medium to long-term whilst maintaining the Company's status as a venture capital trust.

INVESTMENT POLICY

The Company's investment policy is to create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation. Investing across a range of companies and sectors reduces exposure to particular markets and individual companies. The changes to the VCT legislation in November 2015 and those announced in the November 2017 Budget mean that there is greater emphasis on earlier stage growth businesses focussing on the application and development of innovation.

To this end, the Company will invest in UK businesses across a broad range of sectors including but not limited to software, information technology and telecommunications, retail and brands, business services, manufacturing and industrial services and healthcare. These investments will primarily be in unquoted UK companies which meet the definition of a Qualifying Investment, in order to maintain the Company's Venture Capital Trust status. It is anticipated that the majority of these businesses will be re-investing their profits for growth and the investments will, therefore, comprise mainly equity instruments. In order to limit the risk to the portfolio that is derived from any particular investment, at the point of investment no more than 15 per cent of the Company by value will be in any one investment.

Borrowing

The Company funds the investment programmes out of its own resources and has no borrowing facilities for this purpose.

Co-investment

British Smaller Companies VCT plc and British Smaller Companies VCT2 plc ("the VCTs") have in aggregate priority in all investment opportunities meeting the VCT qualifying criteria that require up to £4.5 million of equity. Amounts above £4.5 million will be allocated one third to YFM's co-investment funds and two thirds to the VCTs. Where there are opportunities for the VCTs to co-invest with each other the basis for allocation is 60 per cent to the Company and 40 per cent to British Smaller Companies VCT2 plc. The Board of the Company has discretion as to whether or not to take up or, where British Smaller Companies VCT2 plc does not take its allocation, increase its allocation in such co-investment opportunities.

Asset Mix

Pending investment in VCT-qualifying securities, surplus cash is primarily held in interest bearing instant access, and short-notice bank accounts and investment funds listed on a recognised stock exchange (including FCA authorised and regulated UCITS funds). Subsequent to the Finance (No. 2) Act 2015 investments can no longer be made in non-qualifying quoted investments traded on an unregulated exchange. This change therefore now excludes most AIM investments in this category.

INVESTMENT REVIEW

The Company's portfolio at 30 September 2018 had a value of £66.78 million consisting of £64.30 million (96 per cent) in unquoted investments and £2.48 million (4 per cent) in quoted investments. The largest single investment represents 8.4 per cent of the net asset value.

Over the six months to 30 September 2018 the portfolio saw an underlying value gain of £3.17 million from the ongoing portfolio comprising £2.69 million from the unquoted portfolio and £0.48 million from the quoted portfolio.

The most significant upward movements in the period were:

· ACC Aviation

· Matillion Limited

· Deep-Secure Ltd

· Gill Marine Holdings Limited

£3.41 million

£1.12 million

£1.02 million

£0.65 million

The increase in ACC's valuation during the period has resulted from a very strong underlying trading performance and a recent increase in your Company's equity ownership following a reorganisation.

These gains were offset by companies which saw profits impacted by difficult trading conditions:

· Seven Technologies Holdings Limited

· DisplayPlan Holdings Limited

· e2E Engineering Limited

· Traveltek Group Holdings Limited

down £0.82 million

down £0.74 million

down £0.68 million

down £0.45 million

New and Follow-on Investments

In the six months to September 2018 the rate of new investment has increased. So far this year your Company has completed two new investments totalling £3.12 million.

The new investments comprise:

· £1.80 million into Arcus Global Limited (15.6 weeks for advance assurance)

· £1.32 million into Hutchinson Networks Limited (10.4 weeks for advance assurance)

There has been some improvement in HMRC's rate of response to advance assurance applications, although our experience hasn't yet seen clearance within their best practice guidance of 15 working days. However, HMRC has changed its guidance which would allow your Company to make some investments without obtaining advance assurance. The Board continues to keep these developments under review.

Realisation of Investments

During the six months to 30 September 2018 the Company generated £1.52 million from disposals and repayments of loans. An additional £0.84 million was generated from the realisation of a fixed income security and listed investment funds.

A detailed analysis of all investments realised in the period to 30 September 2018 can be found in note 6.

 

INVESTMENT PORTFOLIO

The top 10 investments had a combined value of £41.0 million, 61.4 per cent of the total portfolio.

Name of Company

Sector

Date of initial investment

Current

cost

 

 

 

Investment

Valuation

at 30 September

2018

 

Proceeds

to date

 

 

Realised and unrealised value

to date

 

£000

£000

£000

£000

ACC Aviation (via Newacc (2014) Limited)

Business Services

Nov 14

220

7,159

1,848

9,007

Matillion Limited

Software

Nov 16

2,666

6,063

-

6,063

Mangar Health Limited

Healthcare

Jan 14

2,460

4,446

-

4,446

Intelligent Office UK (IO Outsourcing Limited t/a Intelligent office)

Business Services

May 14

2,934

4,438

-

4,438

Deep-Secure Limited

Software

Dec 09

1,000

3,875

-

3,875

Gill Marine Holdings Limited

Retail

Sep 13

2,500

3,261

-

3,261

Business Collaborator Limited

Software

Nov 14

2,010

3,130

-

3,130

Eikon Holdco Limited

Software

Mar 18

3,000

3,000

-

3,000

GTK (Holdco) Limited

Manufacturing

Oct 13

222

2,883

1,832

4,715

Springboard Research Holdings Limited

Business Services

Oct 14

2,647

2,699

-

2,699

Total top 10 investments

19,659

40,954

3,680

44,634

Remaining unquoted portfolio

KeTech Enterprises Limited

Software

Nov 15

2,000

2,669

-

2,669

Leengate Holdings Limited

Manufacturing

Dec 13

1,401

2,415

-

2,415

Friska Limited

Retail

Jul 17

1,800

1,803

-

1,803

Arcus Global Limited

Software

May 18

1,800

1,800

-

1,800

Sipsynergy

(via Hosted Network Services Limited)

Software

Jun 16

1,770

1,358

-

1,358

Hutchinson Networks Limited

Software

Apr 18

1,320

1,320

-

1,320

Wakefield Acoustics

 (via Malvar Engineering Limited)

Manufacturing

Dec 14

1,080

1,302

75

1,377

DisplayPlan Holdings Limited

Business Services

Jan 12

130

1,122

1,521

2,643

Ncam Technologies Limited

Software

Mar 18

1,466

1,100

-

1,100

Traveltek Group Holdings Limited

Software

Oct 16

1,470

1,090

-

1,090

Macro Art Holdings Limited

Business Services

Jun 14

720

1,070

540

1,610

Biz2Mobile Limited

Software

Oct 16

1,500

932

-

932

£0.75 million and below

Other investments

8,346

5,361

2,778

8,139

Total unquoted investments

44,462

64,296

8,594

72,890

Quoted portfolio

£0.75 million and below

Other investments

688

2,484

3,023

5,507

Total quoted investments

688

2,484

3,023

5,507

Total portfolio

45,150

66,780

11,617

78,397

Full disposals since 31 March 2002

33,176

-

70,419

70,419

Full disposals prior to 31 March 2002

5,748

-

1,899

1,899

Total investment portfolio 

84,074

66,780

83,935

150,715

The charts on page 13 of the interim report show the composition of the portfolio as at 30 September 2018 by industry sector, age of investment, investment instrument and the value compared to cost.

 

PRINCIPAL RISKS AND UNCERTAINTIES

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Accounts for the year ended 31 March 2018. The Board acknowledges that there is regulatory risk and continues to manage the Company's affairs in such a manner as to comply with section 274 of the Income Tax Act 2007.

In summary, the principal risks are:

· Loss of approval as a Venture Capital Trust;

· Economic;

· Investment and strategic;

· Regulatory;

· Reputational;

· Operational;

· Financial;

· Market/liquidity.

Full details of the principal risks can be found in the financial statements for the year ended 31 March 2018 on pages 28 and 29, a copy of which is available at www.bscfunds.com.

 

DIRECTOR'S RESPONSIBILITIES STATEMENT

The directors of British Smaller Companies VCT plc confirm that, to the best of their knowledge, the condensed set of financial statements in this interim report have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the EU, and give a true and fair view of the assets, liabilities, financial position and profit and loss of British Smaller Companies VCT plc, and that the interim management report includes a true and fair review of the information required by DTR 4.2.7R and DTR 4.2.8R.

The directors of British Smaller Companies VCT plc are listed in note 9 of these interim financial statements.

 

By order of the Board

 

 

 

Helen Sinclair

Chairman

21 November 2018

 

UNAUDITED STATEMENT OF COMPREHENSIVE INCOME

for the six months ended 30 September 2018

 

Unaudited 6 months ended

30 September 2018

Unaudited 6 months ended

30 September 2017

 

Notes

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

Gains (losses) on investments held at fair value

-

3,228

3,228

-

(67)

(67)

Income

2

1,180

-

1,180

1,102

-

1,102

Gains on disposal of investments

6

-

79

79

-

630

630

Total income

1,180

3,307

4,487

1,102

563

1,665

Administrative expenses:

Investment Adviser's fee

(215)

(646)

(861)

(220)

(661)

(881)

Other expenses

(246)

(40)

(286)

(264)

-

(264)

(461)

(686)

(1,147)

(484)

(661)

(1,145)

Profit (loss) before taxation

719

2,621

3,340

618

(98)

520

Taxation

3

(58)

58

-

(72)

72

-

Profit (loss) for the period

661

2,679

3,340

546

(26)

520

Total comprehensive income (loss) for the period

661

2,679

3,340

546

(26)

520

Basic and diluted earnings (loss) per ordinary share

5

0.61p

2.45p

3.06p

0.50p

(0.02)p

0.48p

 

The Total column of this statement represents the Company's Unaudited Statement of Comprehensive Income, prepared in accordance with International Financial Reporting Standards as adopted by the European Union ('IFRSs'). The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (issued in November 2014 and updated in February 2018 with consequential amendments - "SORP") published by the Association of Investment Companies.

 

UNAUDITED BALANCE SHEET

as at 30 September 2018

 

Notes

Unaudited

30 September

2018

 

Unaudited

30 September

2017

 

Audited

31 March

2018

 

£000

£000

£000

Assets

Non-current assets

Investments

66,780

56,430

61,756

Listed investment funds

2,391

-

2,336

Fixed income security

-

710

706

Financial assets at fair value through profit or loss

6

69,171

57,140

64,798

Trade and other receivables

1,580

1,123

1,284

70,751

58,263

66,082

Current assets

Trade and other receivables

534

1,855

1,733

Cash on fixed term deposit

7,001

9,001

9,001

Cash and cash equivalents

7,093

15,568

10,057

14,628

26,424

20,791

Liabilities

Current liabilities

Trade and other payables

(161)

(713)

(736)

Net current assets

14,467

25,711

20,055

Net assets

85,218

83,974

86,137

Shareholders' equity

Share capital

11,517

11,342

11,342

Share premium account

1,052

-

-

Capital reserve

48,101

56,024

53,422

Investment holding gains and losses

21,600

13,917

18,146

Revenue reserve

2,948

2,691

3,227

Total shareholders' equity

85,218

83,974

86,137

Net asset value per ordinary share

7

78.6p

77.0p

79.6p

 

UNAUDITED STATEMENT OF CHANGES IN EQUITY

for the six months ended 30 September 2018

 

Share

capital

Share

premium

account

Capital Redemption Reserve

Capital

reserve

Investment

holding

gains and

losses

Revenue

reserve

Total

equity

£000

£000

£000

£000

£000

£000

£000

At 31 March 2017

11,101

35,519

221

23,686

15,400

2,145

88,072

Revenue return for the period

-

-

-

-

-

618

618

Capital expenses

-

-

-

(661)

-

-

(661)

Investment holding loss on investments held at fair value

-

-

-

-

(67)

-

(67)

Realisation of investments in the period

-

-

-

630

-

-

630

Taxation

-

-

-

72

-

(72)

-

Total comprehensive income (expense) for the period

-

-

-

41

(67)

546

520

Issue of shares - DRIS

241

1,505

-

-

-

-

1,746

Issue costs of ordinary shares*

-

(14)

-

-

-

-

(14)

Cancellation of share premium account, net of costs

-

(37,010)

(221)

37,221

-

-

(10)

Purchase of own shares

-

-

-

(190)

-

-

(190)

Dividends

-

-

-

(6,150)

-

-

(6,150)

Total transactions with owners

241

(35,519)

(221)

30,881

-

-

(4,618)

Realisation of prior year investment holding gains

-

-

-

1,416

(1,416)

-

-

At 30 September 2017

11,342

-

-

56,024

13,917

2,691

83,974

Revenue return for the period

-

-

-

-

-

589

589

Capital expenses

-

-

-

(629)

-

-

(629)

Investment holding gain on investments held at fair value

-

-

-

-

3,285

-

3,285

Realisation of investments in the period

-

-

-

(401)

-

-

(401)

Taxation

-

-

-

53

-

(53)

-

Total comprehensive (expense) income for the period

-

-

-

(977)

3,285

536

2,844

Purchase of own shares

-

-

-

(681)

-

-

(681)

Total transactions with owners

-

-

-

(681)

-

-

(681)

Realisation of prior year investment holding losses

-

-

-

(944)

944

-

-

At 31 March 2018

11,342

-

-

53,422

18,146

3,227

86,137

 

Revenue return for the period

-

-

-

-

-

719

719

 

Capital expenses

-

-

-

(686)

-

-

(686)

 

Investment holding gain on investments held at fair value

-

-

-

-

3,228

-

3,228

 

Realisation of investments in the period

-

-

-

79

-

-

79

 

Taxation

-

-

-

58

-

(58)

-

 

Total comprehensive (expense) income for the period

-

-

-

(549)

3,228

661

3,340

 

Issue of shares - DRIS

175

1,063

-

-

-

-

1,238

 

Issue costs of ordinary shares*

-

(11)

-

-

-

-

(11)

 

Purchase of own shares

-

-

-

(1,164)

-

-

(1,164)

 

Unclaimed dividends

-

-

-

6

-

-

6

 

Dividends

-

-

-

(3,388)

-

(940)

(4,328)

 

Total transactions with owners

175

1,052

-

(4,546)

-

(940)

(4,259)

 

Realisation of prior year investment holding losses

-

-

-

(226)

226

-

-

 

At 30 September 2018

11,517

1,052

-

48,101

21,600

2,948

85,218

 

*Issue costs include both fundraising costs (where applicable) and costs incurred from the Company's DRIS.

 

Reserves available for distribution

Under the Companies Act 2006 the capital reserve and the revenue reserve are distributable reserves. The table below shows amounts that are available for distribution.

Capital reserve

Revenue reserve

Total

£000

£000

£000

Distributable reserves as above

48,101

2,948

51,049

Less : Interest and dividends not yet distributable

-

(2,155)

(2,155)

 

: Cancelled share premium not yet distributable

(16,074)

-

(16,074)

 

Reserves available for distribution*

32,027

793

32,820

* subject to filing these interim financial statements at Companies House.

The capital reserve (£48,101,000) and the revenue reserve (£2,948,000) are both distributable reserves. These reserves total £51,049,000, representing a decrease of £5,600,000 in the period since 31 March 2018. The directors also take into account the level of the investment holding gains and losses reserve and the future requirements of the Company when determining the level of dividend payments.

Of the potentially distributable reserves of £51,049,000 shown above, £2,155,000 relates to interest and dividends receivable from 2019 onwards and £16,074,000 to cancelled share premium which becomes distributable from 1 April 2019 onwards (see below).

Total share premium previously cancelled will be available for distribution from the following dates.

£000

1 April 2019

6,295

1 April 2020

8,288

1 April 2021

1,491

Cancelled share premium not yet distributable

16,074

 

UNAUDITED STATEMENT OF CASH FLOWS

for the six months ended 30 September 2018

Notes

Unaudited

6 months

ended

30 September

2018

Unaudited

6 months

ended

30 September

2017

Audited

year

ended

31 March 2018

£000

£000

£000

Profit before taxation

3,340

520

3,364

Decrease in trade and other payables

(523)

(3,164)

(3,142)

Increase in trade and other receivables

(220)

(893)

(161)

Gain on disposal of investments

(79)

(630)

(229)

(Gains) losses on investments held at fair value

(3,228)

67

(3,218)

Capitalised interest and dividends

-

-

(89)

Net cash outflow from operating activities

(710)

(4,100)

(3,475)

Cash flows from investing activities

Purchase of financial assets at fair value through profit or loss

6

(3,251)

(3,122)

(10,586)

Proceeds from sale of financial assets at fair value through profit or loss

6

2,032

4,191

6,144

Deferred consideration

1,278

213

269

Cash maturing from fixed term deposit

2,000

4,023

4,023

Net cash inflow (outflow) from investing activities

2,059

5,305

(150)

Cash flows from financing activities

Issue of ordinary shares

-

4,244

4,245

Costs of ordinary share issues*

(11)

(118)

(118)

Purchase of own shares

(1,164)

(190)

(871)

Share premium cancellation costs

-

(10)

(10)

Dividends paid

4

(3,138)

(4,410)

(4,411)

Net cash outflow from financing activities

(4,313)

(484)

(1,165)

Net (decrease) increase in cash and cash equivalents

(2,964)

721

(4,790)

Cash and cash equivalents at the beginning of the period

10,057

14,847

14,847

Cash and cash equivalents at the end of the period

7,093

15,568

10,057

 

*Issue costs include both fundraising costs and expenses incurred from the Company's DRIS.

 

EXPLANATORY NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

1 General Information, Basis of Preparation and Principal Accounting Policies

These interim statements have been approved by the directors whose names appear at note 9, each of whom has confirmed that to the best of their knowledge:

• the interim management report includes a true and fair review of the information required by rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules; and

• the interim statements have been prepared in accordance with IAS 34 'Interim financial reporting' and the Disclosure and Transparency Rules of the Financial Conduct Authority.

The interim statements are unaudited but have been reviewed by the auditors pursuant to the International Standard of Review Engagements 2410 (UK and Ireland) guidance on Review of Interim Financial Information Performed by the Independent Auditor of the Entity. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 March 2018 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 March 2018. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.

The accounting policies and methods of computation followed in the interim statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 March 2018. New standards coming into force during the period have not had a material impact on these interim financial statements.

The financial statements for the year ended 31 March 2018 were prepared in accordance with the International Financial Reporting Standards (IFRSs) as adopted by the European Union and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. Where guidance set out in the SORP is consistent with the requirements of IFRS, the financial statements have been prepared in compliance with the recommendations of the SORP.

The Company has carried out an assessment of accounting standards, amendments and interpretations that have been issued by the IASB and that are effective for the current reporting period. These include IFRS 9 Financial Instruments and IFRS 15 Revenue from Contracts with Customers. The Company has determined that IFRS 15 and other amendments/interpretations that are newly effective do not affect the Company's performance or position. In respect of IFRS 9 which replaces IAS 39, the Company continues to account for its investment assets at fair value through profit or loss as permitted by IFRS 9. Trade receivables continue to be accounted for at amortised cost and the Company now applies the new IFRS 9 expected credit loss impairment model to these financial assets. The impact of recognising impairment based on expected credit losses rather than on an incurred basis is minimal.

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated.

Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least twelve months from the date these interim statements were approved. As at 30 September 2018 the Company held cash balances and fixed term deposits with a combined value of £14,094,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy. The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these interim statements.

 

2 Income

Unaudited

6 months ended

30 September

2018

£000

Unaudited

6 months ended

30 September

2017

£000

Income from investments

- Dividends from unquoted companies

406

234

- Dividends from AIM quoted companies

9

5

415

239

- Interest on loans to unquoted companies

652

769

Income from investment portfolio

1,067

1,008

Income from listed investment funds

37

-

Fixed interest Government securities

3

8

Income from investments held at fair value through profit or loss

1,107

1,016

Interest on bank deposits

73

86

1,180

1,102

 

3 Taxation

Unaudited 6 months ended

30 September 2018

Unaudited 6 months ended

30 September 2017

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

Profit (loss) before taxation

719

2,621

3,440

618

(98)

520

Profit before taxation multiplied by the standard small company rate of corporation tax in UK of 19.0% (2017: 19.0%)

137

498

635

117

(18)

99

Effect of:

UK dividends received

(79)

-

(79)

(45)

-

(45)

Non-taxable profits on investments

-

(628)

(628)

-

(107)

(107)

Excess expenses

-

72

72

-

53

53

Tax charge (credit)

58

(58)

-

72

(72)

-

 

The Company has no provided, or unprovided, deferred tax liability in either period.

Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.

Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

 

4 Dividends

Amounts recognised as distributions to equity holders in the period:

 

Unaudited

6 months ended

30 September 2018

Unaudited

6 months ended

30 September 2017

Audited

Year ended

31 March 2018

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

£000

£000

£000

Interim dividend for the year ended 31 March 2019 of 4.0p (2018: 5.75p) per ordinary share

940

3,388

4,328

-

6,150

6,150

-

6,150

6,150

Shares allotted under DRIS

(1,238)

(1,746)

(1,746)

Unclaimed dividends

48

6

7

Dividends paid in the Statement of Cash Flows

3,138

4,410

4,411

5 Basic and Diluted Earnings (Loss) per Ordinary Share and Changes in Share Capital

The basic and diluted earnings per ordinary share is based on the profit after tax attributable to equity shareholders of £3,340,000 (30 September 2017: £520,000) and 109,168,052 (30 September 2017: 108,626,142) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted revenue earnings per ordinary share is based on the revenue profit attributable to equity shareholders of £661,000 (30 September 2017: £546,000) and 109,168,052 (30 September 2017: 108,626,142) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted capital earnings (loss) per ordinary share is based on the capital profit (loss) attributable to equity shareholders of £2,679,000 (30 September 2017: loss of £26,000) and 109,168,052 (30 September 2017: 108,626,142) ordinary shares being the weighted average number of ordinary shares in issue during the period.

During the period the Company allotted 1,751,747 new ordinary shares in respect of its dividend re-investment scheme.

The Company has repurchased 1,589,025 of its own shares in the period and these shares are held in the capital reserve. The total of 6,814,043 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period.

The Company has no securities that would have a dilutive effect in any period. Consequently basic and diluted earnings per ordinary share are equivalent at 30 September 2018, 31 March 2018 and 30 September 2017.

6 Financial Assets at Fair Value through Profit or Loss

IFRS 13, in respect of financial instruments that are measured in the balance sheet at fair value, requires disclosure of fair value measurements by level within the following fair value measurement hierarchy:

Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. These instruments are included in Level 1 and comprise listed investment funds, AIM quoted investments and other fixed income securities classified as held at fair value through profit or loss.

Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. The Company held no such instruments in the current or prior year.

Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as earnings or sales multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. The majority of the Company's investments fall into this category.

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it was included at the beginning of each accounting period. There have been no transfers between these classifications in the period (2017: none).

The change in fair value for the current and previous year is recognised through profit or loss. All items held at fair value through profit or loss were designated as such upon initial recognition.

Valuation of Investments

Initial Measurement: Financial assets are initially measured at fair value. The best estimate of the initial fair value of a financial asset that is either quoted or not quoted in an active market is the transaction price (i.e. cost).

Subsequent Measurement: The International Private Equity and Venture Capital (IPEV) Valuation Guidelines ("the Guidelines") identify six of the most widely used valuation methodologies for unquoted investments. The Guidelines advocate that the best valuation methodologies are those that draw on external, objective market-based data in order to derive a fair value.

Full details of the methods used by the Company were set out on page 56 of the financial statements for the year ended 31 March 2018, a copy of which can be found at www.bscfunds.com. Where investments are in quoted stocks, fair value is set at the market price.

The primary methods used for valuing non-quoted investments, and the key assumptions relating to them are:

Price of recent investment, reviewed for changes in fair value: This represents the cost of the investment or the price at which a significant amount of new investment has been made by an independent third party adjusted, if necessary, for factors relevant to the background of the specific investment. The value of the investment is assessed for changes or events that would imply either a reduction or increase to its fair value through comparison of financial, technical and marketing milestones set at the time of investment. Where it is considered that the fair value no longer approximates to the cost of the recent investment an estimated adjustment to the cost, based on objective data, will be made to the investment's carrying value.

Earnings multiple: A multiple that is appropriate and reasonable, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of that company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies.

Sales multiples and industry valuation benchmarks: Where appropriate comparator companies can be identified, multiples of revenues may be used as a valuation benchmark.

Movements in investments at fair value through profit or loss during the six months to 30 September 2018 are summarised as follows:

 

IFRS 13 measurement classification

Level 3

Unquoted

Investments

 

 

£000

Level 1

Quoted

Equity

Investments

 

£000

Total Quoted and Unquoted

 

£000

Level 1

Listed Investment Funds

 

£000

 

Level 1

Fixed Income Securities

 

£000

 

Total

Investments

 

 

 

£000

Opening cost

42,793

732

43,525

2,431

696

46,652

Opening valuation gain

16,772

1,459

18,231

(95)

10

18,146

Opening fair value at 1 April 2018

59,565

2,191

61,756

2,336

706

64,798

Additions at cost

3,120

-

3,120

131

-

3,251

Disposal proceeds

(1,005)

(240)

(1,245)

(131)

(704)

(2,080)

Net (loss) gain on disposal

(78)

54

(24)

-

(2)

(26)

Change in fair value

2,694

479

3,173

55

-

3,228

Closing fair value at 30 September 2018

64,296

2,484

66,780

2,391

-

69,171

Closing cost

44,462

688

45,150

2,421

-

47,571

Closing valuation gain

19,834

1,796

21,630

(30)

-

21,600

Closing fair value at 30 September 2018

64,296

2,484

66,780

2,391

-

69,171

The net loss on disposal in the table above is £26,000 whereas a gain of £79,000 is shown in the Statement of Comprehensive Income. The difference comprises the gain of £105,000 arising on deferred proceeds in respect of assets which have been disposed of and are not included within the investment portfolio at the period end.

Level 3 valuations include assumptions based on non-observable data, such as discounts applied either to reflect changes in fair value of financial assets held at the price of recent investment, or to adjust earnings multiples.

IFRS13 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to fair value measurement. Each unquoted portfolio company has been reviewed and both downside and upside alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternative the value of the unquoted investments would be £4,596,000 (7.1 per cent) lower. Using the upside alternative the value would be increased by £4,674,000 (7.3 per cent).

Of the Company's investments, 93 per cent are in unquoted companies held at fair value (31 March 2018: 92 per cent). The valuation methodology for these investments includes the application of externally produced sales multiples and FTSE® PE multiples. Therefore the value of the unquoted element of the portfolio is also indirectly affected by price movements on the listed market. Those using earnings and sales multiple methodologies include judgements regarding the level of discount applied to that multiple. A 10 per cent decrease in the discount applied would have increased the net assets attributable to the Company's shareholders and the total profit by £5,429,000 (6.4 per cent of net assets). An equal change in the opposite direction would have decreased net assets attributable to the Company's shareholders and the total profit by the same amount.

Of the Company's equity investments, 4 per cent are quoted on AIM (31 March 2018: 4 per cent) and 3 per cent (31 March 2018: 4 per cent) are investment funds listed on the main market of the London Stock Exchange (including FCA authorised and regulated UCITS funds). A 5 per cent increase in stock prices as at 30 September 2018 would have increased the net assets attributable to the Company's shareholders and the total profit for the period by £244,000 (31 March 2018: £226,000). An equal change in the opposite direction would have decreased the net assets attributable to the Company's shareholders and the total profit for the period by an equal amount.

There have been no individual fair value adjustments downwards during the period that exceeded 5 per cent of the total assets of the Company (31 March 2018: none).

The following disposals and loan repayments took place during the period (all companies are unquoted unless otherwise stated).

Net

proceeds

from sale

 

Cost

 

Opening

carrying

value as at

1 April 2018

Gain (loss)

over

opening

carrying

value

Profit

(loss)

on

 original

cost

 

£000

£000

£000

£000

£000

Unquoted investments

ACC Aviation (via NewACC (2014) Limited)

922

922

922

-

-

Harris Hill Limited

57

57

57

-

-

Macro Art Holdings Limited

26

26

26

-

-

PowerOasis Limited

-

445

78

(78)

(445)

Quoted investments

AB Dynamics plc

192

16

151

41

176

EKF Diagnostics plc

48

27

35

13

21

Total from disposals in the period

1,245

1,493

1,269

(24)

(248)

Deferred consideration received:

Ness (Holdings) Limited

-

-

63

(63)

-

Selima Holding Company Ltd

278

-

110

168

278

Total from quoted and unquoted investments

1,523

1,493

1,442

81

30

Fixed income securities

704

696

706

(2)

8

Listed investment funds

131

143

131

-

(12)

Total proceeds

2,358

2,332

2,279

79

26

 

The proceeds in the table above total £2,358,000, whereas the amounts shown for proceeds and deferred consideration in the Statement of Cash Flows total £3,310,000. The difference relates to the timing differences arising between the recognition of the deferred income and its receipt in cash.

7 Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £85,218,000 (30 September 2017 and 31 March 2018: £83,974,000 and £86,137,000 respectively) and 108,352,886 (30 September 2017 and 31 March 2018: 109,107,183 and 108,190,164 respectively) ordinary shares in issue at 30 September 2018.

The 6,814,043 (30 September 2017 and 31 March 2018: 4,307,999 and 5,225,018) treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 September 2018.

The Company has no securities which would have a dilutive effect in any period. Consequently, basic and diluted net asset values are equivalent at 30 September 2018, 31 March 2018 and 30 September 2017.

8 Total Return

Total Return per share is calculated on cumulative dividends paid of 140.4 pence per ordinary share (30 September 2017 and 31 March 2018: 136.4 pence per ordinary share) plus the net asset value as calculated in note 7.

9 Directors

The directors of the Company are: Mrs H Sinclair, Mr CWER Buchan and Mr R Cook.

10 Post Balance Sheet Events

Subsequent to 30 September 2018 the Company has realised part of its quoted portfolio raising total proceeds of £375,000, in line with the value of the investments at 30 September 2018.

11 Other Information

Copies of the interim report can be obtained from the Company's registered office: 5th Floor, Valiant Building, 14 South Parade, Leeds, LS1 5QS or from www.bscfunds.com.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

 

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR KMMZMZMGGRZM
Date   Source Headline
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.